NASDAQ$SBRA

Sabra Health Care REIT Inc · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

Sabra Health Care REIT's Q1 2022 results were announced, along with a business update, showcasing stability in the portfolio and strategic investments.

Sabra Health Care REIT reported a net income of $0.18 per diluted common share for Q1 2022. The company maintained a strong Net Debt to Adjusted EBITDA ratio of 5.11x and collected 99.5% of forecasted rents since the pandemic's start. They also acquired a managed senior housing community for $26.0 million.

  • Net income was $0.18 per diluted common share.
  • FFO was $0.39 per share, and Normalized FFO was $0.38 per share.
  • AFFO and Normalized AFFO were both $0.39 and $0.38 per share, respectively.
  • The company maintained a strong Net Debt to Adjusted EBITDA ratio of 5.11x.

Headline financials

Total Revenue

$163M

Previous: $152M+7.0%
EPS (adj)

$0.38

Previous: $0.39-2.6%
Net Debt to Adjusted EBITDA

5.11

Previous: 4.84+5.6%
Capital Expenditures

-$31.4M

Previous: -$39.5M+20.5%
Free Cash Flow

$9.23M

Previous: -$6.04M+252.7%
Net Income

$40.6M

Previous: $33.4M+21.4%
Operating Income

$152M

Previous: $142M+7.6%
Gross Profit

$163M

Previous: $152M+7.0%
Cash & Equivalents

$24.8M

Previous: $24.9M-0.2%
Total Assets

$5.88B

Previous: $5.96B-1.3%
Stock-Based Comp

$2.46M

Previous: $2.29M+7.3%

Revenue & EPS history

Sabra Health Care REIT · Revenue · Quarterly

$163M

Q1 2022+7%vs Q1 2021
Beat estimate in 11 of 15 quarters(73%)
ActualEstimate

Revenue by segment

Sabra Health Care REIT · $163M total across 3 segments · Q1 2022

  • Rental and related revenues
    $110M-3.1%
  • Resident fees and services
    $42.2M+17.2%
  • Interest and other income
    $11M+273.8%

Forward guidance

Sabra is focusing on digestible investments for growth and diversification and projects skilled nursing exposure to be at historical lows by year end. They expect to fund investments with available liquidity and proceeds from asset sales.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

-0.5%

Avg return

Earnings day

-0.2%

Avg return

5 days after

-0.4%

Avg return

30 days after

45%

27 / 60 earnings

Positive

+10.4%

Q1 2022

Best reaction

-13.1%

Q3 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.5%+0.1%-2.3%
Q3 2025+2.3%+4.2%+11.7%
Q1 2025+1.2%+0.1%-0.2%
Q4 2024-1.0%-0.8%+4.3%
Q3 2024-4.8%-4.1%-4.3%
Q2 2024-0.1%-1.1%+4.7%
Q1 2024-1.7%-1.7%-5.1%
Q4 2023+0.4%+0.4%+6.0%
Q3 2023+0.7%+2.0%+1.6%
Q2 2023+0.8%-0.9%-1.2%
Q1 2023-0.5%+1.7%+1.7%
Q4 2022-4.2%-6.3%-22.0%
Q3 2022-13.1%-3.5%-7.1%
Q2 2022+0.0%+2.9%-4.0%
Q1 2022+10.4%+6.0%+10.4%
Q4 2021-3.9%-0.7%+5.6%
Q3 2021-2.1%-0.1%-11.2%
Q2 2021-3.7%-4.7%-8.7%
Q1 2021-2.2%+0.0%-1.3%
Q4 2020+1.7%-3.6%-0.8%
Q3 2020-4.0%+15.7%+27.6%
Q2 2020+4.4%+7.7%+5.9%
Q1 2020-5.7%-1.6%+35.6%
Q4 2019-3.5%-11.1%-50.1%
Q3 2019+3.3%+0.6%-6.4%
Q2 2019+5.5%+4.5%+8.5%
Q1 2019-1.6%+0.5%-0.5%
Q4 2018-2.7%-9.6%-2.0%
Q3 2018-0.6%-1.4%-12.9%
Q2 2018-0.3%-0.3%+3.4%
Q1 2018+3.3%+2.9%+7.6%
Q4 2017+2.8%+4.8%+0.2%
Q3 2017-1.5%-2.7%-2.7%
Q2 2017+1.6%+0.9%-4.1%
Q1 2017-10.2%-8.8%-14.2%
Q4 2016+0.6%+5.4%+6.7%
Q3 2016-8.9%-7.2%-0.4%
Q2 2016+1.6%+2.4%+6.6%
Q1 2016+4.4%
Q4 2015+8.3%
Q3 2015-2.9%
Q2 2015-4.6%
Q1 2015-6.0%
Q4 2014-0.9%
Q3 2014-0.9%
Q2 2014-2.0%
Q1 2014-2.6%
Q4 2013+0.8%
Q3 2013+4.1%
Q2 2013-7.3%
Q1 2013+2.4%
Q4 2012+0.0%
Q3 2012+2.6%
Q2 2012+3.0%
Q1 2011-4.6%
Q1 2012+2.4%
Q4 2011+5.1%
Q3 2011+7.5%
Q2 2011+3.9%
Q4 2010-6.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro